Furthermore, RASSF1A promoter hypermethylation was reported as a prognostic indicator in renal cell carcinoma, non-small cell lung cancer, neuroblastoma, melanoma, endometrial cancer and breast cancer [11]–[18]. The gene discussed is RASSF1; the disease is breast carcinoma.